Valved Graft PMCF Study
Start Date
7/13/2021
Completion Date
9/1/2029
Summary
Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
VAVGJ
CAVGJ
Conditions
Locations
University Hospital - Univ. of Alabama at Birmingham (UAB)
Birmingham, Alabama 35294
United States
University of Michigan
Ann Arbor, Michigan 48104
United States
Mission Health & Hospitals
Asheville, North Carolina 28801
United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania 19104
United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania 15213
United States
Klinik Floridsdorf
Vienna, 1012
Austria
Rigshospitalet
Copenhagen, 2100
Denmark
CHU de Besancon - Jean Minjoz
Besançon, 25030
France
CHRU Lille
Lille, 59037
France
Groupe Hospitalier Bichat - Claude Bernard
Paris, 75877
France
Herz-und Diabetes Zentrum NRW
Bad Oeynhausen, 32545
Germany
Deutsches Herzzentrum Berlin
Berlin, 13353
Germany
Klinikum Links der Weser
Bremen, 28277
Germany
Medizinische Hochschule Hannover
Hanover, 30625
Germany
Onassis Cardiac Surgery Center
Athens, 17674
Greece
Policlinico S.Orsola-Malpighi
Bologna, 40138
Italy
Ospedale San Raffaele
Milan, 20132
Italy
Policlinico San Donato
San Donato Milanese, 20097
Italy
Wojewodzki Szpital Zespolony w Kielcach
Kielce, 25-736
Poland
Krakowski Szpital Specjalistyczny im. Jana Pawla II
Krakow, 31-202
Poland
Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi
Lodz, 92-213
Poland
The Cardinal Stefan Wyszynski Institute of Cardiology
Warsaw, 04-628
Poland
Hospital Universitario del Vinalopó
Elche, 03293
Spain
Hospital Universitario Son Espases
Palma de Mallorca, 07120
Spain
James Cook University Hospital
Middlesbrough, TS43BW
United Kingdom